会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 사스 바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물
    • SARS病毒抗原和微生物的细胞表面表达载体转化用于生产疫苗用于预防或治疗SARS
    • KR1020040104936A
    • 2004-12-13
    • KR1020040040894
    • 2004-06-04
    • 주식회사 바이오리더스(주)제노락 BL한국생명공학연구원(주)엠디랩
    • 성문희김철중정창민홍승표이종수최재철김광주니치구로다부하령
    • C12N15/86
    • C07K14/005A61K39/00A61K2039/523C07K2319/00C12N9/93C12N15/74C12N2710/20022C12N2770/20022Y02A50/472Y02A50/476
    • PURPOSE: A cell surface expression vector of SARS virus antigen and a microorganism transformed thereby are provided. The transformed microorganism and antigen protein produced therefrom are useful in the production of a vaccine for the prevention or treatment of SARS. CONSTITUTION: The cell surface expression vector of SARS virus antigen comprises one or more than two genes selected from genes encoding polygammaglutamic acid synthetase complex, pgsB, pgsC and pgsA; and a gene encoding a spike antigen protein of SARS coronavirus or a nucleocapsid antigen protein, wherein the spike antigen protein is SARS SA, SARS SB, SARS SC or SARS SBC; the nucleocapsid antigen is SARS NA, SARS NB or SARS N; and the expression vector is pHCE2LB:pgsA-SARS SA, pHCE2LB:pgsA-SARS SC or pHCE2LB:pgsA-SARS SBC. The transformed microorganism is produced by transforming with the cell surface expression vector of SARS virus antigen, wherein the microorganism is selected from Escherichia coli, Salmonella typhi, Salmonella typhimurium, Vibrio cholera, Mycobacterium bovis, Shigella sp., Bacillus sp., lactic acid bacteria, Staphylococcus sp., Listeria monocytogenes and Streptococcus sp.
    • 目的:提供SARS病毒抗原和由此转化的微生物的细胞表面表达载体。 由此产生的转化的微生物和抗原蛋白质可用于生产用于预防或治疗SARS的疫苗。 构成:SARS病毒抗原的细胞表面表达载体包含选自编码聚氨基丁酸合成酶复合物,pgsB,pgsC和pgsA的基因中的一种或两种以上的基因; 以及编码SARS冠状病毒或核衣壳抗原蛋白的尖峰抗原蛋白的基因,其中尖峰抗原蛋白为SARS SA,SARS SB,SARS SC或SARS SBC; 核衣壳抗原为SARS NA,SARS NB或SARS N; 表达载体为pHCE2LB:pgsA-SARS SA,pHCE2LB:pgsA-SARS SC或pHCE2LB:pgsA-SARS SBC。 通过用SARS病毒抗原的细胞表面表达载体转化产生转化的微生物,其中微生物选自大肠杆菌,伤寒沙门氏菌,鼠伤寒沙门氏菌,霍乱弧菌,牛分枝杆菌,志贺氏杆菌,芽孢杆菌,乳酸菌 ,葡萄球菌属(Staphylococcus sp。),单核细胞增生利斯特氏菌(Listeria monocytogenes)和链球菌属(Streptococcus sp。)。
    • 3. 发明公开
    • 신규 항시적 고발현 프로모터 및 그 용도
    • 新宪法强力促进者及其使用
    • KR1020080086161A
    • 2008-09-25
    • KR1020070027947
    • 2007-03-22
    • 주식회사 바이오리더스한국생명공학연구원
    • 성문희김철중홍승표부하령이일한김지연김광
    • C12N9/88C12N15/09C12N15/10
    • C12N15/746C12N9/1276
    • A novel constitutive strong promoter is provided to express effectively a target protein on the surface of a microorganism transformed by an expression vector containing the promoter, so that the transformed microorganism is useful as a vaccine carrier. An aldolase promoter isolated from Lactobacillus casei has the nucleotide sequence of SEQ ID NO:1. A microorganism surface expression vector contains the aldolase promoter, polygammaglutamic acid synthetase complex gene selected from pgsA, pgsB and pgsC and a gene encoding a target protein. A method for producing a microorganism vaccine comprises the steps of: (a) transforming a microorganism with the microorganism surface expression vector and culturing the transformed microorganism to express an antigen on the surface of transformed microorganism; and (b) recovering the antigen surface-expressed microorganism, wherein the microorganism is a lactic acid bacterium.
    • 提供了一种新颖的组成型强启动子,以有效地表达由含有启动子的表达载体转化的微生物的表面上的靶蛋白,使得转化的微生物可用作疫苗载体。 从干酪乳杆菌分离的醛缩酶启动子具有SEQ ID NO:1的核苷酸序列。 微生物表面表达载体含有选自pgsA,pgsB和pgsC的醛缩酶启动子,聚氨基amic氨酸合成酶复合物基因和编码靶蛋白的基因。 微生物疫苗的制造方法包括以下步骤:(a)用微生物表达载体转化微生物,培养转化的微生物以在转化的微生物的表面上表达抗原; 和(b)回收抗原表面表达微生物,其中微生物是乳酸菌。
    • 4. 发明授权
    • 신규 알카리성 리파제, 이를 생산하는 신규 바실러스 균주 및 리파제 대량생산 방법
    • 신규알카리성리파제,이를생산하산신규바실러스균주및리파제대량생산방
    • KR100463350B1
    • 2004-12-29
    • KR1020010061667
    • 2001-10-06
    • 한국생명공학연구원주식회사 바이오리더스
    • 성문희오태광김형권최윤호김광석김영선김철중송재준김광배진우신광순부하령이상철
    • C12N9/14
    • PURPOSE: Provided are a novel alkaline lipase, a novel bacillus sp. strain producing the same, and a method of producing the lipase massively. The non-toxicity bacillus sp. strain is capable of being used in food industry, and the lipase is used for quantitative determination of lipid content. CONSTITUTION: The novel alkaline lipase shows thermostability at 40 deg.C and has an optimum temperature of activity at 35 deg.C. Further, it has no changes with calcium concentrations, and has an optimum activity at pH 8.5. Its amino acid sequence is represented by the SEQ ID NO:1. The novel bacillus sp. strain, bacillus pumilus B26 strain(KTCC 10081BP) produces the lipase. The lipase is mass-produced by transforming bacillus subtilis DB104 with a recombinant vector pMB26 then culturing the transformant. The transformant strain is bacillus subtilis DB104/pMB26(KCTC 10082BP).
    • 目的:提供了一种新型碱性脂肪酶,一种新型的芽孢杆菌。 产生它的菌株,以及大量生产脂肪酶的方法。 无毒芽孢杆菌 菌株能够在食品工业中使用,并且脂肪酶用于定量测定脂质含量。 构成:新型碱性脂肪酶在40摄氏度显示热稳定性,在35摄氏度时具有最佳活性温度。 此外,钙浓度没有变化,并且在pH 8.5时具有最佳活性。 其氨基酸序列由SEQ ID NO:1表示。 新型芽孢杆菌 菌株,短小芽孢杆菌B26菌株(KTCC10081BP)产生脂肪酶。 通过用重组载体pMB26转化枯草芽孢杆菌DB104然后培养转化体来大量生产脂肪酶。 转化株是枯草芽孢杆菌DB104 / pMB26(KCTC10082BP)。
    • 9. 发明公开
    • 티벡터와 발현벡터로의 기능을 동시에 가지는 플라스미드및 이를 이용한 목적유전자의 발현
    • 具有T矢量和表达载体功能的PLASMID通过一个克隆步骤表达目标蛋白,并使用相同的目标基因表达
    • KR1020050009118A
    • 2005-01-24
    • KR1020030048625
    • 2003-07-16
    • 한국생명공학연구원주식회사 바이오리더스
    • 성문희홍승표최윤호김광이일한박제현송영신부하령
    • C12N15/63
    • C12N15/64
    • PURPOSE: A plasmid having a function of T-vector and expression vector, and expression of a target gene using the same plasmid are provided, which plasmid is easily converted to T-vector, and allows for expression of the target protein through one cloning step. CONSTITUTION: The plasmid pHCE-ROREX having a function of T-vector and expression vector comprises two recognition sites where the T-vector is able to be cloned downstream of a promoter in a vector pHCE which continuously highly expresses a target protein without limitation by a host cell, wherein the recognition site is selected from HphI, MboII, AspEI and XcmI; and a polynucleotide is inserted between two recognition sites. An expression vector is prepared by digesting the plasmid with the recognition enzyme to remove the polynucleotide inserted, and inserting a target gene into the polynucleotide removed site in the plasmid. The method for expression of the target gene comprises transforming a bacterium with the expression vector containing the target gene, and culturing the transformed bacterium.
    • 目的:提供具有T载体和表达载体的功能的质粒和使用相同质粒的靶基因的表达,该质粒易于转化为T载体,并且允许通过一个克隆步骤表达靶蛋白 。 构成:具有T载体和表达载体的功能的质粒pHCE-ROREX包含两个识别位点,其中T载体能够克隆在载体pHCE中的启动子下游,其不断高度表达靶蛋白,而不受 宿主细胞,其中所述识别位点选自HphI,MboII,AspEI和XcmI; 并且在两个识别位点之间插入多核苷酸。 通过用识别酶消化质粒以除去插入的多核苷酸并将靶基因插入质粒中的多核苷酸去除部位来制备表达载体。 用于表达靶基因的方法包括用含有靶基因的表达载体转化细菌,并培养转化的细菌。